ArticleCancer medicine2023

Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective study.

Yuki Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.